InsidersTradesSigma
Discover the complete record of transactions filed by ELMS STEVE, Director. Officer active across 4 companies, notably Marker Therapeutics, Inc.. Aggregated, 5 filings have been recorded. The latest transaction was disclosed on 7 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Steve Elms is a Director at Marker Therapeutics, Inc. and Zosano Pharma Corp. In this role, he participates in the governance of the company and strategic decision-making. His expertise in the biopharmaceutical sector is valuable in guiding research and development initiatives. As a director, he ensures that best practices are followed and that shareholder interests are protected.